BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 24047478)

  • 1. De novo B-cell prolymphocytic leukemia with central nervous system involvement.
    Tatarczuch M; Blombery P; Seymour JF
    Leuk Lymphoma; 2014 Jul; 55(7):1665-7. PubMed ID: 24047478
    [No Abstract]   [Full Text] [Related]  

  • 2. B-cell prolymphocytic leukaemia with a t(4;14) FGFR3/IGH translocation: response to ibrutinib.
    George P; Brown A; Weinkove R
    Pathology; 2020 Jun; 52(4):491-492. PubMed ID: 32349864
    [No Abstract]   [Full Text] [Related]  

  • 3. Smudge cells following treatment with pentostatin in a patient with B-cell prolymphocytic leukemia.
    Yun HD; Waller EK
    Blood; 2013 Jul; 122(4):474. PubMed ID: 24049774
    [No Abstract]   [Full Text] [Related]  

  • 4. Idelalisib-Rituximab induces clinical remissions in patients with TP53 disrupted B cell prolymphocytic leukaemia.
    Eyre TA; Fox CP; Shankara P; Went R; Schuh AH
    Br J Haematol; 2017 May; 177(3):486-491. PubMed ID: 27061924
    [No Abstract]   [Full Text] [Related]  

  • 5. Richter's syndrome of the brain and the spinal cord.
    Graves TD; Collins GP; Parry A
    J Neurol Neurosurg Psychiatry; 2011 Aug; 82(8):943-4. PubMed ID: 20587487
    [No Abstract]   [Full Text] [Related]  

  • 6. A relapsed aggressive NK-cell leukemia with CNS involvement diagnosed by cerebrospinal fluid examination.
    Xu Z; Shier L; Huebsch L
    Diagn Cytopathol; 2016 Apr; 44(4):314-6. PubMed ID: 26890009
    [No Abstract]   [Full Text] [Related]  

  • 7. Relapsed B-cell prolymphocytic leukemia (B-PLL) with distinctive granular inclusion bodies.
    Su MY; Chen TC; Teng CJ; Wu CH
    Int J Lab Hematol; 2024 Aug; 46(4):585-586. PubMed ID: 38284307
    [No Abstract]   [Full Text] [Related]  

  • 8. Ibrutinib therapy is effective in B-cell prolymphocytic leukemia exhibiting MYC aberrations.
    Damlaj M; Al Balwi M; Al Mugairi AM
    Leuk Lymphoma; 2018 Mar; 59(3):739-742. PubMed ID: 28695755
    [No Abstract]   [Full Text] [Related]  

  • 9. Hot and Cold: A Concurrent Warm and Cold Autoimmune Hemolytic Anemia in B-cell Prolymphocytic Leukemia.
    Feld J; Arnason J; O Apos Brien K; Nahas M
    Acta Haematol; 2019; 141(4):222-224. PubMed ID: 30947164
    [No Abstract]   [Full Text] [Related]  

  • 10. An unusual cause of delirium and debility: refractory hypercalcemia in a man with B-cell prolymphocytic leukemia.
    Loh KP; Dahiya S; Brennan MJ
    J Am Geriatr Soc; 2014 Oct; 62(10):2021-2. PubMed ID: 25333559
    [No Abstract]   [Full Text] [Related]  

  • 11. B-prolymphocytic leukemia: Is it time to retire this entity?
    El Hussein S; Khoury JD; Medeiros LJ
    Ann Diagn Pathol; 2021 Oct; 54():151790. PubMed ID: 34293709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Auer Rod-Like Inclusions in B-Cell Prolymphocytic Leukemia.
    Zhao Y; Lv J
    Turk J Haematol; 2019 Nov; 36(4):280-281. PubMed ID: 30238921
    [No Abstract]   [Full Text] [Related]  

  • 13. [CD5-positive B-cell prolymphocytic leukemia].
    Inoue T; Yoshida M; Oowashi K; Yoshida T
    Rinsho Ketsueki; 2010 Jan; 51(1):80-2. PubMed ID: 20134145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated central nervous system relapse in two patients with BCR-ABL-positive acute leukemia while receiving a next-generation tyrosine kinase inhibitor.
    Gaur S; Torabi AR; Corral J
    In Vivo; 2014; 28(6):1149-53. PubMed ID: 25398814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Successful treatment of B-cell prolymphocytic leukemia (B-PLL) with FCR-Lite (fludarabine, cyclophosphamide, rituximab) protocol].
    Telek B; Batár P; Rejto L; Udvardy M
    Orv Hetil; 2010 Aug; 151(31):1261-3. PubMed ID: 20656663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and diagnosis of hairy cell leukemia.
    Quest GR; Johnston JB
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):180-92. PubMed ID: 26614896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent chronic lymphocytic leukemia and prolymphocytic leukemia derived from two separate B-cell clones.
    Cao F; Amato D; Wang C
    Am J Hematol; 2011 Sep; 86(9):782. PubMed ID: 21465516
    [No Abstract]   [Full Text] [Related]  

  • 18. Central nervous system involvement of primary cutaneous diffuse large B cell lymphoma-leg type diagnosed according to the WHO 2008 classification.
    Aoki K; Arima H; Tabata S; Matsushita A; Ishikawa T; Takahashi T
    Ann Hematol; 2012 Dec; 91(12):1975-6. PubMed ID: 22592652
    [No Abstract]   [Full Text] [Related]  

  • 19. Lenalidomide for aggressive B-cell lymphoma involving the central nervous system?
    Cox MC; Mannino G; Lionetto L; Naso V; Simmaco M; Spiriti MA
    Am J Hematol; 2011 Nov; 86(11):957. PubMed ID: 21990093
    [No Abstract]   [Full Text] [Related]  

  • 20. Prolymphocytic Leukemia: New Insights in Diagnosis and in Treatment.
    Collignon A; Wanquet A; Maitre E; Cornet E; Troussard X; Aurran-Schleinitz T
    Curr Oncol Rep; 2017 Apr; 19(4):29. PubMed ID: 28324286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.